Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
Armistice Capital, LLC's stake in Eledon Pharmaceuticals, Inc. fell to 4.99% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC's stake in Eledon Pharmaceuticals, Inc. fell to 4.99%, 3,137,553 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 3,137,553
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 3,137,553 |
| Steven Boyd | 4.99% | 3,137,553 |
Source
Related
- Eledon Pharmaceuticals, Inc.
- Armistice Capital, LLC
- Eledon Pharmaceuticals, Inc. shareholders
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026